PAM
CRBP icon

Panagora Asset Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Panagora Asset Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151K Buy
+16,087
New +$152K ﹤0.01% 1133
2020
Q4 		– Sell
-350
Closed -$19K – 2828
2020
Q3 		$19K Hold
350
– – ﹤0.01% 2218
2020
Q2 		$88K Hold
350
– – ﹤0.01% 1825
2020
Q1 		$55K Buy
+350
New +$59.2K ﹤0.01% 1859

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Panagora Asset Management's CRBP Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Corbus Pharmaceuticals (CRBP) in Q2 2026: 16,087 shares worth $151K. The stake represents ﹤0.01% of the portfolio and ranks #1133 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in CRBP as recently as Q3 2020.

Panagora Asset Management first reported a position in CRBP in Q1 2020 and has held it in 4 quarters since. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Panagora Asset Management held 16,087 shares of Corbus Pharmaceuticals worth $151K as of Q2 2026.
  • Corbus Pharmaceuticals was a new Panagora Asset Management position in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #1133 holding.
  • Panagora Asset Management first reported a position in Corbus Pharmaceuticals in Q1 2020 and has held it in 4 quarters since.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.